Parallel Advisors’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$183K Buy
10,413
+8,759
+530% +$176K ﹤0.01% 1213
2025
Q4
$32.7K Buy
1,654
+773
+88% +$13.9K ﹤0.01% 2063
2025
Q3
$15.4K Sell
881
-72
-8% -$1.07K ﹤0.01% 2378
2025
Q2
$13.3K Buy
953
+301
+46% +$4.85K ﹤0.01% 2373
2025
Q1
$12.1K Buy
652
+47
+8% +$701 ﹤0.01% 2356
2024
Q4
$6.81K Buy
605
+166
+38% +$1.94K ﹤0.01% 2529
2024
Q3
$5.19K Hold
439
﹤0.01% 2598
2024
Q2
$3.43K Buy
+439
New +$2.87K ﹤0.01% 2641
2023
Q3
Sell
-56
Closed -$322 3365
2023
Q2
$322 Buy
+56
New +$362 ﹤0.01% 3186

Other funds holding ALHC

Parallel Advisors's ALHC Position: Q1 2026 in Review

Parallel Advisors increased its Alignment Healthcare (ALHC) stake by 530% in Q1 2026, buying an estimated $176K and bringing the position to 10,413 shares worth $183K. The position accounts for ﹤0.01% of the portfolio, ranked #1213.

Parallel Advisors first reported a position in ALHC in Q2 2023 and has held it in 9 quarters since. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • Parallel Advisors held 10,413 shares of Alignment Healthcare worth $183K as of Q1 2026.
  • Parallel Advisors bought 8,759 Alignment Healthcare shares in Q1 2026, an estimated $176K.
  • Alignment Healthcare made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #1213 holding.
  • Parallel Advisors first reported a position in Alignment Healthcare in Q2 2023 and has held it in 9 quarters since.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.